ArticleEvidence-based complementary and alternative medicine : eCAM2023

Retracted: Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer.

Evidence-Based Complementary And Alternative MedicinePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.